Literature DB >> 7626291

Oxidant tone regulates IL-8 production in epithelium infected with respiratory syncytial virus.

J G Mastronarde1, M M Monick, G W Hunninghake.   

Abstract

Respiratory syncytial virus (RSV) is an important respiratory pathogen that preferentially infects epithelial cells in the airway, and causes a local inflammatory response. Although it has been previously demonstrated that RSV-infected airway epithelial produce cytokines, including interleukin-8 (IL-8), which contributes to the inflammatory response, the regulation of this effect of RSV is unknown. To further characterize the mechanisms by which RSV infection triggers release of IL-8, we first exposed cultured A549 cells to RSV, and measured IL-8 release via enzyme-linked immunosorbent assays (ELISA), and IL-8 messenger RNA (mRNA) induction via Northern blot analysis. We observed a dose- and time-dependent release of IL-8 in response to RSV. The optimal dose of RSV was 10(4) TCID50/ml, and maximal release of IL-8 was measured at 72 to 96 h after infection. RSV induced a biphasic (early and late) increase in IL-8 mRNA. The early phase was independent of viral infection, whereas the more pronounced late phase required the presence of live virus and infection of the epithelium. Partial (< 50%) cytopathic effects were noted at 48 h and progressed to 75% at 96 h. The monolayer was still intact at 96 h. Inhibitors of nitric oxide, including NG-monomethyl-L-arginine (L-NMMA), NG-nitro-L-arginine methyl ester (L-NAME), and aminoguanidine had no effect on IL-8 release or IL-8 mRNA induction. We did, however, demonstrate a dose-dependent decrease in IL-8 release and IL-8 mRNA induction in RSV-infected epithelial treated with the antioxidants dimethyl sulfoxide (DMSO) or 5,5-dimethyl-1-pyrroline-N-oxide (DMPO). Peak effects were noted at a concentration of 2% DMSO and 50 microM DMPO. The antioxidants did not inhibit viral replication or infection. This data suggest that RSV-induced IL-8 production in airway epithelium is mediated via changes in oxidant tone. The data also suggest a potential therapeutic role for antioxidants in RSV infections.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7626291     DOI: 10.1165/ajrcmb.13.2.7626291

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  13 in total

1.  Antioxidant mimetics modulate oxidative stress and cellular signaling in airway epithelial cells infected with respiratory syncytial virus.

Authors:  Yashoda M Hosakote; Narayana Komaravelli; Nicolas Mautemps; Tianshuang Liu; Roberto P Garofalo; Antonella Casola
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-09-28       Impact factor: 5.464

2.  Differential role for TLR3 in respiratory syncytial virus-induced chemokine expression.

Authors:  Brian D Rudd; Ezra Burstein; Colin S Duckett; Xiaoxia Li; Nicholas W Lukacs
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

3.  Inhibition of viral replication reverses respiratory syncytial virus-induced NF-kappaB activation and interleukin-8 gene expression in A549 cells.

Authors:  M A Fiedler; K Wernke-Dollries; J M Stark
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

4.  Respiratory syncytial virus-mediated NF-kappa B p65 phosphorylation at serine 536 is dependent on RIG-I, TRAF6, and IKK beta.

Authors:  Fabrice Yoboua; Alexis Martel; Annick Duval; Espérance Mukawera; Nathalie Grandvaux
Journal:  J Virol       Date:  2010-04-21       Impact factor: 5.103

Review 5.  Respiratory syncytial virus infection: mechanisms of redox control and novel therapeutic opportunities.

Authors:  Roberto P Garofalo; Deepthi Kolli; Antonella Casola
Journal:  Antioxid Redox Signal       Date:  2012-09-07       Impact factor: 8.401

6.  Post-infection A77-1726 blocks pathophysiologic sequelae of respiratory syncytial virus infection.

Authors:  Ian C Davis; Eduardo R Lazarowski; Fu-Ping Chen; Judy M Hickman-Davis; Wayne M Sullender; Sadis Matalon
Journal:  Am J Respir Cell Mol Biol       Date:  2007-05-31       Impact factor: 6.914

7.  Respiratory syncytial virus and TNF alpha induction of chemokine gene expression involves differential activation of Rel A and NF-kappa B1.

Authors:  Laura R Carpenter; James N Moy; Kenneth A Roebuck
Journal:  BMC Infect Dis       Date:  2002-03-28       Impact factor: 3.090

Review 8.  Gene expression in epithelial cells in response to pneumovirus infection.

Authors:  J B Domachowske; C A Bonville; H F Rosenberg
Journal:  Respir Res       Date:  2001-05-11

Review 9.  Respiratory Syncytial Virus and Cellular Stress Responses: Impact on Replication and Physiopathology.

Authors:  Sandra L Cervantes-Ortiz; Natalia Zamorano Cuervo; Nathalie Grandvaux
Journal:  Viruses       Date:  2016-05-12       Impact factor: 5.048

Review 10.  Redox Biology of Respiratory Viral Infections.

Authors:  Olga A Khomich; Sergey N Kochetkov; Birke Bartosch; Alexander V Ivanov
Journal:  Viruses       Date:  2018-07-26       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.